Studies on conducting vessels have shown that iNOS overexpression in endotoxemia contributes to endothelial dysfunction by reducing the activity of endothelial nitric oxide synthase (eNOS) (55). The gene discussed is NOS3; the disease is serum lipopolysaccharide activity.